Acute Ischemic Stroke Registry for Endovascular Treatment

Capital Medical University500 enrolled

Overview

The Acute Ischemic Stroke Registry for Endovascular Treatment (AIS-EVT) is an academic, prospective, multicenter, observational registry study. Consecutive stroke patients treated with endovascular treatment will be enrolled in stroke centers. Baseline information and clinical follow-up information at 90 days of stroke onset are collected. Data collected include demographics, comorbidities, pathogenesis, blood pressures, stroke severity on admission, time intervals, reperfusion condition, and functional outcome, et al.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Acute Ischemic Stroke

Interventions

Endovascular TreatmentPROCEDURE

Re-open the occluded cerebral artery using endovascular treatment

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. Diagnosis of acute ischemic stroke; 2. Imaging confirmed intracranial large vessel occlusion: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1); 3. Initiation of any type of endovascular treatment, including intra-arterial thrombolysis, mechanical thrombectomy, aspiration, angioplasty, and stenting; 4. Verbal and written informed consent was provided at the time of admission by patients or their legal authorized representatives. Exclusion Criteria: No evidence of large vessel occlusion on digital subtraction angiography.

Locations (1)

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

The modified Rankin Scale score at 90 days

The range of the modified Rankin Scale is from 0 to 6. A higher score indicates a worse outcome. 0-No symptoms; 1-No significant disability; 2-Slight disability; 3-Moderate disability; 4-Moderately severe disability; 5-Severe disability; 6-Dead.

Time frame: 90 days

Central Contacts

Xunming Ji, MD

CONTACT

010-83198952 jixm@ccmu.edu.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.